Aktiv Pharma Group
Aktiv Pharma Group is a pharmaceutical services and technology company specializing in drug delivery market solutions. It has developed innovative drug delivery platforms including autoinjectors like ARAI and PenPal, as well as high-barrier polymer film containers like ARCH-Vial. The company supports the entire development process from design to sterile fill-finish through its vertically integrated CDMO organization. With a focus on reliability, safety, usability, and drug stability, Aktiv aims to deliver peace of mind in pharmaceutical delivery.
Industries
Nr. of Employees
small (1-50)
Aktiv Pharma Group
100 Technology Drive, Suite 250A, Broomfield, CO 80021
Products
Modular high-reliability autoinjector platform for emergency countermeasures
A rugged, modular autoinjector platform engineered for high reliability and multiple configurations (single-liquid, dual-needle, reconstitution) intended for emergency medical countermeasures and severe-environment use.
At-home routine self-injection autoinjector platform
A user-centric autoinjector platform engineered for routine at-home injections with multi-sensory feedback and design features to improve ease-of-use and adherence.
Film-based flexible single-dose primary container for reconstitution
A flexible, high-barrier primary container enclosed in a protective shell designed as a glass-free single-dose presentation suitable for reconstitution and sensitive biologics, with options for opaque or clear protective shells.
Modular high-reliability autoinjector platform for emergency countermeasures
A rugged, modular autoinjector platform engineered for high reliability and multiple configurations (single-liquid, dual-needle, reconstitution) intended for emergency medical countermeasures and severe-environment use.
At-home routine self-injection autoinjector platform
A user-centric autoinjector platform engineered for routine at-home injections with multi-sensory feedback and design features to improve ease-of-use and adherence.
Film-based flexible single-dose primary container for reconstitution
A flexible, high-barrier primary container enclosed in a protective shell designed as a glass-free single-dose presentation suitable for reconstitution and sensitive biologics, with options for opaque or clear protective shells.
Services
Vertically integrated services covering device design and customization, equipment development, prototyping, quality systems, cleanroom operations, and sterile fill-finish for drug-device combination projects.
GMP pilot-scale formulation, aseptic fill-finish operations, and device assembly to support clinical manufacturing and scale-up activities.
Design, prototyping and customization of delivery devices and associated manufacturing equipment enabled by an in-house machine shop and rapid iteration processes.
Implementation and maintenance of quality management systems and regulatory-ready processes for combination products and sterile manufacturing.
Analytical and stability testing for biologics and nucleic acid formulations, including cryogenic stability and freeze-thaw assessments.
Vertically integrated services covering device design and customization, equipment development, prototyping, quality systems, cleanroom operations, and sterile fill-finish for drug-device combination projects.
GMP pilot-scale formulation, aseptic fill-finish operations, and device assembly to support clinical manufacturing and scale-up activities.
Design, prototyping and customization of delivery devices and associated manufacturing equipment enabled by an in-house machine shop and rapid iteration processes.
Implementation and maintenance of quality management systems and regulatory-ready processes for combination products and sterile manufacturing.
Analytical and stability testing for biologics and nucleic acid formulations, including cryogenic stability and freeze-thaw assessments.
Expertise Areas
- Drug-device combination product development
- Contract development and manufacturing (CDMO) for sterile products
- Autoinjector and delivery device engineering
- Primary container materials and barrier film development
Key Technologies
- Film-based high-barrier polymer primary containers
- Modular autoinjector mechanisms (pressurized-gas actuation)
- Dual-chamber reconstitution systems
- Sterile fill-finish (GMP)
News & Updates
Strong IP Portfolio with 43 Issued Patents and 57 Pending Applications
Aktiv has amassed a significant IP fortress supporting its innovative drug delivery systems.
Strong IP Portfolio with 43 Issued Patents and 57 Pending Applications
Aktiv has amassed a significant IP fortress supporting its innovative drug delivery systems.